Edmond J LaVoie

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Acinetobacter Baumannii

Top Venues

Antibiotics (Basel, Switzerland)

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

This page only lists publications with an associated author ORCID identifier.

Publications

Eric J Bryan, Qi Qiao, Yuxuan Wang, Jacques Y Roberge, Edmond J LaVoie, Daniel S Pilch
A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Eric J Bryan, Qi Qiao, Yuxuan Wang, Jacques Y Roberge, Edmond J LaVoie, Daniel S Pilch
A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Eric J Bryan, Qi Qiao, Yuxuan Wang, Jacques Y Roberge, Edmond J LaVoie, Daniel S Pilch
A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Hye Yeon Sagong, Jesus D Rosado-Lugo, Eric J Bryan, Edgar Ferrer-González, Yiling Wang, Yanlu Cao, Ajit K Parhi, Daniel S Pilch, Edmond J LaVoie
Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 31 (10) (2022)
Hye Yeon Sagong, Joseph D Bauman, Aitor Nogales, Luis Martínez-Sobrido, Eddy Arnold, Edmond J LaVoie
Aryl and Arylalkyl Substituted 3-Hydroxypyridin-2(1H)-ones: Synthesis and Evaluation as Inhibitors of Influenza A Endonuclease. ChemMedChem 14 (12) (2019)